Ying Xü

Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China

Ying Huang, Rui Yang, Ying Xü et al. · 2020 · 131 citations · Full text

Long Covid, Virus Epidemiology, Cardiovascular Disease +15

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study

Ying Xü, Mingran Shao, Ning Liu et al. · BMC Infectious Diseases · 2021 · 41 citations · Full text

Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of <i>Helicobacter pylori</i> infection previously failed in eradication: A real‐world, retrospective clinical study in China

Wen Gao, Guigen Teng, Chi Wang et al. · Helicobacter · 2022 · 40 citations · Full text

Prevention of peritoneal dialysis-related peritonitis by regular patient retraining via technique inspection or oral education: a randomized controlled trial

Ying Xü, Yuhui Zhang, Bin Yang et al. · Nephrology Dialysis Transplantation · 2019 · 33 citations · Full text